ASTHX Fees and Costs — AllianzGI Short Term Bond Fund, Class A
Data updated: 2020-12-09
The net expense ratio is 0.64%: a 0.30% management fee, a 0.25% 12b-1 fee plus 2.26% other expenses, less a 2.17% fee waiver. This share class carries a maximum front-end sales load of 2.25% and a deferred sales charge of up to 0.50%. Portfolio turnover was 46%.
ASTHX Fees and Expenses
Annual operating expenses and sales charges of ASTHX. Prospectus, as of September 30, 2019.
| Annual operating expenses | |
|---|---|
| Management fee | 0.30% |
| 12b-1 fee | 0.25% |
| Other expenses | 2.26% |
| Gross expense ratio | 2.81% |
| Fee waiver | −2.17% |
| Net expense ratio | 0.64% |
| Sales charges | |
|---|---|
| Max front load | 2.25% |
| Max deferred load | 0.50% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
ASTHX Costs Over Time
On $10,000 invested in ASTHX, assuming 5% a year before costs, total costs come to $681 over 5 years, cutting the return by 1.15% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $276 | $225 | $225 |
| Fund expenses (net expense ratio 0.64%) | $66 | $206 | $358 |
| Lost growth on money paid in costs | $11 | $46 | $98 |
| Total costs | $353 | $476 | $681 |
| Value after costs | $10,147 | $11,100 | $12,082 |
| Impact on return, per year | 3.53% | 1.46% | 1.15% |
ASTHX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2020.
- Explicit cost rate (commissions ÷ average net assets): —
- Total broker commissions: —
- Bought from dealers (principal trades, not a cost): $313.0M
- Portfolio turnover (prospectus): 46%
- Securities lending: none during the year
ASTHX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| State Street Bank and Trust Company | $271.9M | 89.22% |
| Goldman Sachs & Co. LLC | $6.7M | 2.20% |
| MarketAxess Corporation | $5.8M | 1.89% |
| Citigroup Global Markets Inc. | $4.2M | 1.38% |
| Bofa Securities, Inc. | $3.4M | 1.12% |
| J.P. Morgan Securities LLC | $3.4M | 1.11% |
| Morgan Stanley & Co. LLC | $2.6M | 0.84% |
| Barclays Capital Inc. | $2.4M | 0.80% |
| Wells Fargo Securities, LLC | $2.3M | 0.77% |
| Jefferies LLC | $2.1M | 0.68% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.